ID   RBSK_HUMAN              Reviewed;         322 AA.
AC   Q9H477; A9UK04; B4DV96;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-JUN-2023, entry version 175.
DE   RecName: Full=Ribokinase {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000303|PubMed:17585908};
DE            Short=RK {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000303|PubMed:17585908};
DE            EC=2.7.1.15 {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|PubMed:17585908};
GN   Name=RBKS {ECO:0000255|HAMAP-Rule:MF_03215}; Synonyms=RBSK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wightman P.J.;
RL   Thesis (2000), University of Edinburgh, United Kingdom.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li X., Mao Y., Xie Y.;
RT   "Cloning and characterization of RBS protein.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY
RP   REGULATION.
RX   PubMed=17585908; DOI=10.1016/j.febslet.2007.06.009;
RA   Park J., van Koeverden P., Singh B., Gupta R.S.;
RT   "Identification and characterization of human ribokinase and comparison of
RT   its properties with E. coli ribokinase and human adenosine kinase.";
RL   FEBS Lett. 581:3211-3216(2007).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 11-322 IN COMPLEX WITH ADP; SODIUM
RP   AND MAGNESIUM.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human ribokinase.";
RL   Submitted (JAN-2006) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the phosphorylation of ribose at O-5 in a reaction
CC       requiring ATP and magnesium. The resulting D-ribose-5-phosphate can
CC       then be used either for sythesis of nucleotides, histidine, and
CC       tryptophan, or as a component of the pentose phosphate pathway.
CC       {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|PubMed:17585908}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + D-ribose = ADP + D-ribose 5-phosphate + H(+);
CC         Xref=Rhea:RHEA:13697, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:47013, ChEBI:CHEBI:78346, ChEBI:CHEBI:456216;
CC         EC=2.7.1.15; Evidence={ECO:0000255|HAMAP-Rule:MF_03215,
CC         ECO:0000269|PubMed:17585908};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_03215};
CC       Note=Requires a divalent cation, most likely magnesium in vivo, as an
CC       electrophilic catalyst to aid phosphoryl group transfer. It is the
CC       chelate of the metal and the nucleotide that is the actual substrate.
CC       {ECO:0000255|HAMAP-Rule:MF_03215};
CC   -!- ACTIVITY REGULATION: Activated by a monovalent cation that binds near,
CC       but not in, the active site. The most likely occupant of the site in
CC       vivo is potassium. Ion binding induces a conformational change that may
CC       alter substrate affinity (By similarity). Competitively inhibited by
CC       phosphonoacetic acid, etidronate, 2-carboxethylphosphonic acid, N-
CC       (phosphonomethyl)glycine, N-(phosphonomethyl)iminodiacetic acid and
CC       clodronate (PubMed:17585908). {ECO:0000255|HAMAP-Rule:MF_03215,
CC       ECO:0000269|PubMed:17585908}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.17 mM for ribose (in the presence of 10 mM inorganic phosphate)
CC         {ECO:0000269|PubMed:17585908};
CC         KM=3.39 mM for ribose (in the presence of 5 mM inorganic phosphate)
CC         {ECO:0000269|PubMed:17585908};
CC         KM=6.62 mM for ribose (in the presence of 2 mM inorganic phosphate)
CC         {ECO:0000269|PubMed:17585908};
CC         KM=30.43 mM for ribose (in the presence of 1 mM inorganic phosphate)
CC         {ECO:0000269|PubMed:17585908};
CC         KM=0.07 mM for ATP (in the presence of 5 mM inorganic phosphate)
CC         {ECO:0000269|PubMed:17585908};
CC         KM=0.08 mM for ATP (in the presence of 2 mM inorganic phosphate)
CC         {ECO:0000269|PubMed:17585908};
CC         KM=0.1 mM for ATP (in the presence of 1 mM inorganic phosphate)
CC         {ECO:0000269|PubMed:17585908};
CC   -!- PATHWAY: Carbohydrate metabolism; D-ribose degradation; D-ribose 5-
CC       phosphate from beta-D-ribopyranose: step 2/2. {ECO:0000255|HAMAP-
CC       Rule:MF_03215}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P0A9J6, ECO:0000255|HAMAP-
CC       Rule:MF_03215}.
CC   -!- INTERACTION:
CC       Q9H477; Q96AP0: ACD; NbExp=2; IntAct=EBI-10982959, EBI-717666;
CC       Q9H477; Q9H477: RBKS; NbExp=4; IntAct=EBI-10982959, EBI-10982959;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P25332,
CC       ECO:0000255|HAMAP-Rule:MF_03215}. Nucleus
CC       {ECO:0000250|UniProtKB:P25332, ECO:0000255|HAMAP-Rule:MF_03215}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H477-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H477-2; Sequence=VSP_054380;
CC   -!- SIMILARITY: Belongs to the carbohydrate kinase PfkB family. Ribokinase
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_03215}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ404857; CAC12877.1; -; mRNA.
DR   EMBL; AY643715; AAT64917.1; -; mRNA.
DR   EMBL; AK300989; BAG62608.1; -; mRNA.
DR   EMBL; AC021171; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110084; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017425; AAH17425.1; -; mRNA.
DR   CCDS; CCDS1762.1; -. [Q9H477-1]
DR   RefSeq; NP_001274509.1; NM_001287580.1.
DR   RefSeq; NP_071411.1; NM_022128.2. [Q9H477-1]
DR   PDB; 2FV7; X-ray; 2.10 A; A/B=11-322.
DR   PDB; 5BYC; X-ray; 1.95 A; A/B=1-322.
DR   PDB; 5BYD; X-ray; 2.10 A; A/B=1-322.
DR   PDB; 5BYE; X-ray; 1.75 A; A/B=1-322.
DR   PDB; 5BYF; X-ray; 2.00 A; A/B=1-322.
DR   PDB; 5C3Y; X-ray; 2.60 A; A/B/C/D/E/F/G/H/I/J/K/L=1-322.
DR   PDB; 5C3Z; X-ray; 1.90 A; A/B=1-322.
DR   PDB; 5C40; X-ray; 1.50 A; A/B=1-322.
DR   PDB; 5C41; X-ray; 1.95 A; A/B/C/D=1-322.
DR   PDB; 6WJZ; X-ray; 1.80 A; A/B=14-322.
DR   PDB; 6WK0; X-ray; 2.00 A; A/B/C/D=14-322.
DR   PDBsum; 2FV7; -.
DR   PDBsum; 5BYC; -.
DR   PDBsum; 5BYD; -.
DR   PDBsum; 5BYE; -.
DR   PDBsum; 5BYF; -.
DR   PDBsum; 5C3Y; -.
DR   PDBsum; 5C3Z; -.
DR   PDBsum; 5C40; -.
DR   PDBsum; 5C41; -.
DR   PDBsum; 6WJZ; -.
DR   PDBsum; 6WK0; -.
DR   AlphaFoldDB; Q9H477; -.
DR   SMR; Q9H477; -.
DR   BioGRID; 122046; 23.
DR   IntAct; Q9H477; 8.
DR   MINT; Q9H477; -.
DR   STRING; 9606.ENSP00000306817; -.
DR   GlyGen; Q9H477; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9H477; -.
DR   PhosphoSitePlus; Q9H477; -.
DR   BioMuta; RBKS; -.
DR   DMDM; 20139730; -.
DR   EPD; Q9H477; -.
DR   jPOST; Q9H477; -.
DR   MassIVE; Q9H477; -.
DR   MaxQB; Q9H477; -.
DR   PaxDb; Q9H477; -.
DR   PeptideAtlas; Q9H477; -.
DR   ProteomicsDB; 5255; -.
DR   ProteomicsDB; 80790; -. [Q9H477-1]
DR   Antibodypedia; 13898; 157 antibodies from 22 providers.
DR   DNASU; 64080; -.
DR   Ensembl; ENST00000302188.8; ENSP00000306817.3; ENSG00000171174.15. [Q9H477-1]
DR   GeneID; 64080; -.
DR   KEGG; hsa:64080; -.
DR   MANE-Select; ENST00000302188.8; ENSP00000306817.3; NM_022128.3; NP_071411.1.
DR   UCSC; uc002rlo.3; human. [Q9H477-1]
DR   AGR; HGNC:30325; -.
DR   CTD; 64080; -.
DR   DisGeNET; 64080; -.
DR   GeneCards; RBKS; -.
DR   HGNC; HGNC:30325; RBKS.
DR   HPA; ENSG00000171174; Tissue enhanced (liver).
DR   MIM; 611132; gene.
DR   neXtProt; NX_Q9H477; -.
DR   OpenTargets; ENSG00000171174; -.
DR   PharmGKB; PA134951602; -.
DR   VEuPathDB; HostDB:ENSG00000171174; -.
DR   eggNOG; KOG2855; Eukaryota.
DR   GeneTree; ENSGT00390000005743; -.
DR   HOGENOM; CLU_027634_2_3_1; -.
DR   InParanoid; Q9H477; -.
DR   OMA; DIVLIQQ; -.
DR   OrthoDB; 1217765at2759; -.
DR   PhylomeDB; Q9H477; -.
DR   TreeFam; TF105770; -.
DR   BRENDA; 2.7.1.15; 2681.
DR   PathwayCommons; Q9H477; -.
DR   Reactome; R-HSA-71336; Pentose phosphate pathway.
DR   SABIO-RK; Q9H477; -.
DR   SignaLink; Q9H477; -.
DR   SIGNOR; Q9H477; -.
DR   UniPathway; UPA00916; UER00889.
DR   BioGRID-ORCS; 64080; 14 hits in 1147 CRISPR screens.
DR   ChiTaRS; RBKS; human.
DR   EvolutionaryTrace; Q9H477; -.
DR   GenomeRNAi; 64080; -.
DR   Pharos; Q9H477; Tbio.
DR   PRO; PR:Q9H477; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9H477; protein.
DR   Bgee; ENSG00000171174; Expressed in jejunal mucosa and 164 other tissues.
DR   ExpressionAtlas; Q9H477; baseline and differential.
DR   Genevisible; Q9H477; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004747; F:ribokinase activity; TAS:Reactome.
DR   GO; GO:0019303; P:D-ribose catabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0006098; P:pentose-phosphate shunt; TAS:Reactome.
DR   CDD; cd01174; ribokinase; 1.
DR   Gene3D; 3.40.1190.20; -; 1.
DR   HAMAP; MF_01987; Ribokinase; 1.
DR   InterPro; IPR002173; Carboh/pur_kinase_PfkB_CS.
DR   InterPro; IPR011877; D_ribokin.
DR   InterPro; IPR011611; PfkB_dom.
DR   InterPro; IPR002139; Ribo/fructo_kinase.
DR   InterPro; IPR029056; Ribokinase-like.
DR   PANTHER; PTHR10584:SF166; RIBOKINASE; 1.
DR   PANTHER; PTHR10584; SUGAR KINASE; 1.
DR   Pfam; PF00294; PfkB; 1.
DR   PRINTS; PR00990; RIBOKINASE.
DR   SUPFAM; SSF53613; Ribokinase-like; 1.
DR   PROSITE; PS00584; PFKB_KINASES_2; 1.
DR   TIGRFAMs; TIGR02152; D_ribokin_bact; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Carbohydrate metabolism;
KW   Cytoplasm; Kinase; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Potassium; Reference proteome; Transferase.
FT   CHAIN           1..322
FT                   /note="Ribokinase"
FT                   /id="PRO_0000080092"
FT   ACT_SITE        269
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P0A9J6, ECO:0000255|HAMAP-
FT                   Rule:MF_03215"
FT   BINDING         25..27
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P0A9J6, ECO:0000255|HAMAP-
FT                   Rule:MF_03215"
FT   BINDING         53..57
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P0A9J6, ECO:0000255|HAMAP-
FT                   Rule:MF_03215"
FT   BINDING         154
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P0A9J6, ECO:0000255|HAMAP-
FT                   Rule:MF_03215"
FT   BINDING         199
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03215,
FT                   ECO:0000269|Ref.7"
FT   BINDING         235..240
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03215,
FT                   ECO:0000269|Ref.7"
FT   BINDING         256
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03215,
FT                   ECO:0000269|Ref.7"
FT   BINDING         263
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03215,
FT                   ECO:0000305|Ref.7"
FT   BINDING         265
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000250|UniProtKB:P0A9J6, ECO:0000255|HAMAP-
FT                   Rule:MF_03215"
FT   BINDING         268..269
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03215,
FT                   ECO:0000269|Ref.7"
FT   BINDING         269
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P0A9J6, ECO:0000255|HAMAP-
FT                   Rule:MF_03215"
FT   BINDING         295
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03215,
FT                   ECO:0000269|Ref.7"
FT   BINDING         301
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03215,
FT                   ECO:0000305|Ref.7"
FT   BINDING         304
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03215,
FT                   ECO:0000305|Ref.7"
FT   BINDING         306
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000250|UniProtKB:P0A9J6, ECO:0000255|HAMAP-
FT                   Rule:MF_03215"
FT   BINDING         310
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03215,
FT                   ECO:0000305|Ref.7"
FT   VAR_SEQ         266..322
FT                   /note="GAGDSFVGALAFYLAYYPNLSLEDMLNRSNFIAAVSVQAAGTQSSYPYKKDL
FT                   PLTLF -> CRPGSRPKSEAASVKKQKHYK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054380"
FT   CONFLICT        101
FT                   /note="T -> A (in Ref. 2; AAT64917)"
FT                   /evidence="ECO:0000305"
FT   STRAND          17..21
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          25..31
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          41..43
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          45..52
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           54..64
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          69..78
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           79..90
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          98..101
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          108..113
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          119..124
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           126..130
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           133..138
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           140..145
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          147..151
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           157..169
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          173..176
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           188..191
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          194..199
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           200..207
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           214..225
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   TURN            226..228
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          230..235
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           237..239
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          241..247
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          252..254
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           267..281
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           287..301
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   STRAND          304..306
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           307..310
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           314..316
FT                   /evidence="ECO:0007829|PDB:5C40"
FT   HELIX           319..322
FT                   /evidence="ECO:0007829|PDB:5C40"
SQ   SEQUENCE   322 AA;  34143 MW;  50D0E7161F33E94B CRC64;
     MAASGEPQRQ WQEEVAAVVV VGSCMTDLVS LTSRLPKTGE TIHGHKFFIG FGGKGANQCV
     QAARLGAMTS MVCKVGKDSF GNDYIENLKQ NDISTEFTYQ TKDAATGTAS IIVNNEGQNI
     IVIVAGANLL LNTEDLRAAA NVISRAKVMV CQLEITPATS LEALTMARRS GVKTLFNPAP
     AIADLDPQFY TLSDVFCCNE SEAEILTGLT VGSAADAGEA ALVLLKRGCQ VVIITLGAEG
     CVVLSQTEPE PKHIPTEKVK AVDTTGAGDS FVGALAFYLA YYPNLSLEDM LNRSNFIAAV
     SVQAAGTQSS YPYKKDLPLT LF
//
